CLOVER HEALTH INVESTMENTS, CORP. current report, 01 March 2021

Clover Health Investments, Corp. — Form 8-K Summary

Business Context and Reporting Period

Clover Health Investments, Corp. filed a Current Report on Form 8-K dated March 1, 2021. The filing announces financial results for the fourth quarter and fiscal year ended December 31, 2020. The company is an emerging growth company, and its Class A common stock and redeemable warrants trade on Nasdaq under the symbols CLOV and CLOVW, respectively.

Financial Results and Key Metrics

The filing states that a press release and shareholder letter containing fourth-quarter and full-year 2020 results were furnished as Exhibits 99.1 and 99.2. The provided filing text does not include the exhibits or clear values for revenue, profit or loss, cash flow, margins, debt, liquidity, membership, or other financial metrics.

Material Changes Versus the Prior Comparable Period

The provided text does not disclose specific year-over-year or sequential changes. Comparative financial information may be contained in the furnished press release and shareholder letter, which are not included in the source text.

Guidance, Outlook, Risks, and Unusual Items

  • The filing does not provide operating guidance, forecasts, or detailed management commentary in the text supplied.
  • The company notes that it may disclose material information through SEC filings, press releases, public calls, presentations, webcasts, its investor-relations website, and certain social-media channels.
  • Information posted on social-media channels is stated not to be incorporated by reference into this report or other SEC filings.
  • The financial-results information furnished under Item 2.02, including the exhibits, is not deemed filed for purposes of Section 18 of the Exchange Act and is not incorporated by reference except where expressly provided.

Important Facts for Investors to Verify

  • Review Exhibits 99.1 and 99.2 for the actual fourth-quarter and fiscal-year 2020 financial results.
  • Verify revenue, net income or loss, medical loss ratio, operating expenses, cash flow, cash balance, debt, liquidity, and membership metrics.
  • Check management’s outlook, assumptions, non-GAAP reconciliations, and discussion of risks or contingencies.
  • Confirm whether subsequent SEC filings revise or supplement the information furnished in this Form 8-K.